MiNK Therapeutics, Inc. reports

Company location: New York, NY
Fiscal year end: 31 December

MiNK Therapeutics, Inc. has filed 255 SEC EDGAR filings since 22 Jan 2021

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 126-150 of 255 matching filings.

Per page

25

Current page

6

4

4

Filing date: 18 Jan 2024
Reporting date: 16 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 18 Jan 2024
Reporting date: 18 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Dec 2023
Reporting date: 01 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Dec 2023
Reporting date: 01 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Dec 2023
Reporting date: 01 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 05 Dec 2023
Reporting date: 01 Dec 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-40908

10-Q

Filing date: 14 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40908

FORM 8-K

Filing date: 09 Nov 2023
Reporting date: 09 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40908

8-K

Filing date: 17 Oct 2023
Reporting date: 12 Oct 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4

Filing date: 16 Oct 2023
Reporting date: 12 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 13 Oct 2023
Reporting date: 11 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Oct 2023
Reporting date: 04 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 03 Oct 2023
Reporting date: 29 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 29 Sep 2023
Reporting date: 27 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Sep 2023
Reporting date: 01 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Sep 2023
Reporting date: 01 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Sep 2023
Reporting date: 01 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Sep 2023
Reporting date: 01 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 06 Sep 2023
Reporting date: 01 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 31 Aug 2023
Reporting date: 29 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 28 Aug 2023
Reporting date: 24 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-273906

S-8

Filing date: 11 Aug 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-40908

FORM 8-K

Filing date: 10 Aug 2023
Reporting date: 10 Aug 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-40908

10-Q

Filing date: 10 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-40908

8-K

Filing date: 20 Jun 2023
Reporting date: 13 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .